Editor
Option Care Health CEO John Rademacher said Wednesday the company is standing by its $3.6 billion all-stock bid to buy Amedisys, despite a competing bid for the home health firm from UnitedHealth Group’s Optum unit.
“Our belief is there is significant value to Amedisys shareholders and Option Care shareholders both on the strategic and financial merits of the combination and we continue to work towards that outcome and work to close an…
